Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome b-c1 complex subunit 8 (UQCRQ) is a small, low-molecular-mass protein that forms part of the ubiquinol-cytochrome c reductase complex (Complex III) in the mitochondrial respiratory chain[1][3][7]. UQCRQ acts as a ubiquinone-binding protein and is integral for the electron transfer from ubiquinol to cytochrome c, a process that drives proton translocation across the mitochondrial inner membrane and is essential for oxidative phosphorylation and ATP generation. Mutations in UQCRQ are linked to mitochondrial complex III deficiency, manifesting in various metabolic and neurometabolic diseases[1][3]. Although there are no drugs targeting UQCRQ specifically, inhibitors of Complex III can impact this protein’s function and mitochondrial bioenergetics[7].
Inhibition of Complex III disrupts electron flow from ubiquinol to cytochrome c, collapsing the mitochondrial membrane potential and reducing ATP synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b-c1 complex subunit 8 (UQCRQ).